Article ID Journal Published Year Pages File Type
10070579 European Journal of Surgical Oncology (EJSO) 2005 5 Pages PDF
Abstract
The abundant expression of EZH-2 in CRC cases indicated that EZH-2 may be an oncogene and a prognostic marker for CRC cases. We discovered there was concordant expression of HDAC-1 with EZH-2 in clinical CRC cases, in addition to the fact that higher expression levels of both genes predicted a poor prognosis.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, , , , , ,